Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine

Ornella Corazza, Fabrizio Schifano, Pierluigi Simonato, Suzanne Fergus, Sulaf Assi, Jacqueline Stair, John Corkery, Giuseppina Trincas, Paolo Deluca, Zoe Davey, Ursula Blaszko, Zsolt Demetrovics, Jacek Moskalewicz, Aurora Enea, Giuditta di Melchiorre, Barbara Mervo, Lucia Di Furia, Magi Farre, Liv Flesland, Manuela PasinettiCinzia Pezzolesi, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Aurora Enea, Giuditta di Melchiorre, Elias Sferrazza, Marta Torrens, Peer van der Kreeft, Daniela Zummo, Norbert Scherbaum

Research output: Contribution to journalArticlepeer-review

107 Citations (Scopus)

Abstract

On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of methoxetamine as a new recreational trend is here provided. Those methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, are here discussed as well. It is concluded that the online availability of information on novel psychoactive drugs, such as methoxethanine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast-growing phenomenon. Copyright © 2012 John Wiley & Sons, Ltd.
Original languageEnglish
Pages (from-to)145-9
Number of pages5
JournalHuman Psychopharmacology: Clinical and Experimental
Volume27
Issue number2
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine'. Together they form a unique fingerprint.

Cite this